Why the study?
Both eosinophils and hs-CRP play a major role in the acute inflammatory response of myocardial infarction, but their combined prognostic value for in-hospital adverse events in STEMI patients undergoing primary PCI required evaluation.
Does the combination of reduced eosinophil percentage and elevated hs-CRP predict in-hospital MACEs in STEMI patients undergoing primary PCI?
Does the combination of reduced eosinophil percentage and elevated hs-CRP predict in-hospital MACEs in STEMI patients undergoing primary PCI?
Combined reduced eosinophil percentage and elevated hs-CRP can identify STEMI patients at high risk for in-hospital MACEs following primary PCI.
No takes yet. Share an insight, caveat, or question.
May flag high-risk STEMI patients post-PCI; leaves open incremental value over standard models.
Ye et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: